Financials

  • Market Capitalization 51.81 M
  • Employee 17
  • Founded 2018
  • CEO N/A
  • Website www.instilbio.com
  • Headquarter New York, United States
  • FIGI BBG00ZGYN521
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.03
Relación precio/flujo de caja
151.55

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4268
MCRB
Seres Therapeutics, Inc. - Common Stock
5.62 USD-8.02%-26.54%-3.44%-31.71%53.87 M USD
4272
XLO
Xilio Therapeutics, Inc. - Common Stock
9.24 USD+0.98%-1.60%+15.64%+1183.33%53.43 M USD
4288
MREO
Mereo BioPharma Group plc - American Depositary Shares
0.32 USD-5.88%0.00%+3.23%-81.50%51.08 M USD
4290
TCRT
Alaunos Therapeutics, Inc. - Common Stock
2.08 USD+1.46%+1.96%-12.24%-22.07%50.80 M USD

Noticias